Zura Bio
ZURA
78 hedge funds and large institutions have $151M invested in Zura Bio in 2024 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 30 increasing their positions, 8 reducing their positions, and 5 closing their positions.
420% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 5
275% more repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 8
37% more funds holding
Funds holding: 57 → 78 (+21)
32% more capital invested
Capital invested by funds: $115M → $151M (+$36.2M)
6.69% more ownership
Funds ownership: 51.69% → 58.38% (+6.7%)
9% more call options, than puts
Call options by funds: $1.25M | Put options by funds: $1.14M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
+$14.1M |
| 2 |
B
Braidwell
Stamford,
Connecticut
|
+$9.24M |
| 3 |
BlackRock
New York
|
+$4.37M |
| 4 |
SC
Stempoint Capital
New York
|
+$3.9M |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$2.76M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VA
VR Adviser
New York
|
-$14.9M |
| 2 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$5.15M |
| 3 |
AC
Armistice Capital
New York
|
-$3.83M |
| 4 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
-$1.15M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$1.11M |
ZURA Hedge Fund Activity: Q3 2024 in Review
78 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Zura Bio (ZURA) for Q3 2024, worth a combined $151M — up 32% from $115M a quarter earlier.
Buyers outnumbered sellers: 26 funds opened new ZURA positions and 5 closed out — a net gain of 21 holders — while 30 added to existing stakes and 8 trimmed.
The largest buyer was ADAR1 Capital Management, opening a new position worth an estimated $14.1M. The largest seller was VR Adviser, cutting an estimated $14.9M.
- 78 institutional investors held Zura Bio (ZURA) as of Q3 2024, up from 57 in Q2 2024.
- Funds reported $151M of Zura Bio stock for Q3 2024, up 32% quarter-over-quarter.
- 26 funds opened new Zura Bio positions in Q3 2024 and 5 closed out, a net change of +21 holders.
- The largest Zura Bio buyer in Q3 2024 was ADAR1 Capital Management, an estimated $14.1M added.
- The largest Zura Bio seller in Q3 2024 was VR Adviser, an estimated $14.9M sold.
Based on aggregated 13F filings for Q3 2024.